Cancer researcher. Pure Biochemist. he/him/his. @sloan_kettering. @GC_CUNY. @Hunter_College. An eye for eye only ends up making the whole world blind - Gandhi.
Nothing in biology makes sense except in the light of RNA sequencing, but what if you can't analyze the data? We (mostly Guy) created a software to make your life easy! Read our NEW preprint & RETWEET. Please try it (follow the detailed tutorial) and give us feedback! 🤟🙏
@NathanielEDavid Neat, and the data is compelling. Have seen similar graphs with body weight vs longevity and also heart rate vs longevity. Would be curious to see the tortoise on the far x-axis of this graph!
@jenheemstra So true! I consider myself very fortunate to have @DavidAFosterPhD as my PhD advisor... continues to be my friend, philosopher, and guide🙏
@AbdelWahablab@NEJM @anthonymatomd @TaylorJ_MD@ewang2323@MCThompsonMD Impressive work... congrats! Hopefully, the study will provide the impetus for generation of novel BTK inhibitors (or degraders?) that can target the novel "bypass" mutations.
Today, I’m proud to announce our plan to supercharge the Cancer Moonshot as a central effort of the Biden-Harris Administration.
Our goal is to cut the cancer death rate by at least 50% over the next 25 years.
It’s bold, ambitious, and completely doable.
@UshmaNeill@whitefishlab The talk was amazing and couldn't miss his passion for mentoring the next generation of scientists - Kudos! Great science (and tie). Look forward to the next 10 years and beyond 🥂
The emerging hallmarks of cancer... beautifully sums the exponential growth in understanding and novel paradigms. One ring to encompass them all, one ring to understand them, one ring to define them all, and in remedy conquer them! @CD_AACR 🏆
⭐️SO excited to finally be able to share the January issue of @CD_AACR, which includes "Hallmarks of Cancer: New Dimensions" by #DougHanahan!! https://t.co/M9pue5Q9PE
May I present, the #Tcell: 80% of epitopes in the spike protein recognized by CD8+ T cells are not affected by the mutations in the Omicron variant, two doses may still induce protection against severe disease
OncoKB, @sloan_kettering MSK's precision oncology knowledge base, is now the first somatic human genetic variant database to achieve partial recognition by the @US_FDA! Read the announcement below, and visit our updated website at https://t.co/ftiBFwcPeg.
https://t.co/ovuO7NE9j1
Why do mutations only sometimes cause cancer? In our new @ScienceMagazine paper, we describe a mechanism for this called "oncogenic competence": https://t.co/TqdDUygs3J
In the last decade, we've treated more than 6,000 people with #thyroidcancer by integrating basic biology with the latest in precision medicine to find the best treatments for each person. Watch the video to learn more. #ThyroidCancerAwarenessMonth
https://t.co/NkmT9dSSic